Skip to main content
Year archive

NUFORMIX PLC — 2018 filings

All 20 regulatory filings released by NUFORMIX PLC (NFX) in 2018, sourced directly from the official regulator.

20 Filings
2018 Period
2018 filings (20)
Filing Released Lang
Unaudited Half Year Results
Earnings Release H1 2018
2018-12-20 English
Reports Results from Novel IPF Pre-Clinical Trial
Regulatory Filings
2018-12-03 English
Expansion of NXP001 Agreement & Milestone Payment
Regulatory Filings
2018-11-27 English
Director/PDMR Shareholding
Director's Dealing
2018-09-28 English
Additional New NXP002 Patent Filing
Regulatory Filings
2018-09-28 English
Result of AGM
AGM Information
2018-09-19 English
AGM Resolutions
AGM Information
2018-09-19 English
Convertible Loan Amendment
Regulatory Filings
2018-08-28 English
Final Results
Annual Report FY 2018
2018-07-26 English
Holding(s) in Company
Major Shareholding Notification
2018-07-09 English
Operational Update
Regulatory Filings
2018-07-02 English
Dr Chris Blackwell Appointed NED
Board/Management Information
2018-05-11 English
Holding(s) in Company
Major Shareholding Notification
2018-04-24 English
Stmnt re Share Price Movement
Regulatory Filings
2018-04-11 English
Annual Report and AGM Notice
Annual Report FY 2018
2018-03-31 English
Proxy Form
Proxy Solicitation & Information Statement
2018-03-31 English
Update re: Broker
Regulatory Filings
2018-03-02 English
Holding(s) in Company
Major Shareholding Notification
2018-02-27 English
NXP002 Pilot Study in Lung and Liver Fibrosis
Earnings Release FY 2018
2018-01-31 English
NXP002 Pilot Study in Lung and Liver Fibrosis
Earnings Release FY 2018
2018-01-31 English